New study to uncover diabetes risks in hospitalized kidney patients

NCT ID NCT07354958

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will follow 200 hospitalized adults with chronic kidney disease to see how diabetes and related metabolic problems affect their outcomes. Researchers will track deaths, need for dialysis, and major heart events during the hospital stay. The goal is to better understand these risks to improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict and manage complications in hospitalized patients with both diabetes and chronic kidney disease.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease diabetic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sohag University Hospital

    Sohag, Egypt

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••